ArticleBritish journal of cancer2014

Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer.

C-L Soh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.